A Trojan Horse delivery for treating a rare, potentially deadly, blood-clotting disorder
In this possible treatment, platelet blood cells carry an enzyme needed to prevent clots in TTP, while hiding the enzyme from autoantibody neutralization
24-Sep-2018 -
In proof-of-concept experiments, University of Alabama at Birmingham researchers have highlighted a potential therapy for a rare but potentially deadly blood-clotting disorder, TTP. The researchers deliver this therapeutic enzyme via the cellular equivalent of a Trojan Horse, using tiny blood ...
autoantibodies
blood coagulation
platelets
+1